| Year |
Citation |
Score |
| 2021 |
Mansour R, Ward AR, Lane DM, Loveland KA, Aman MG, Jerger S, Schachar RJ, Pearson DA. ADHD severity as a predictor of cognitive task performance in children with Autism Spectrum Disorder (ASD). Research in Developmental Disabilities. 111: 103882. PMID 33548744 DOI: 10.1016/j.ridd.2021.103882 |
0.329 |
|
| 2021 |
Lee RR, Ward AR, Lane DM, Aman MG, Loveland KA, Mansour R, Pearson DA. Executive Function in Autism: Association with ADHD and ASD Symptoms. Journal of Autism and Developmental Disorders. PMID 33515417 DOI: 10.1007/s10803-020-04852-2 |
0.305 |
|
| 2020 |
Aman MG, Norris M, Kaat AJ, Andrews H, Choo TH, Chen C, Wheeler A, Bann C, Erickson C. Factor Structure of the Aberrant Behavior Checklist in Individuals with Fragile X Syndrome: Clarifications and Future Guidance. Journal of Child and Adolescent Psychopharmacology. PMID 32746626 DOI: 10.1089/Cap.2019.0177 |
0.301 |
|
| 2020 |
Pearson DA, Santos CW, Aman MG, Arnold LE, Lane DM, Loveland KA, Mansour R, Ward AR, Casat CD, Jerger S, Schachar RJ, Bukstein OG, Cleveland LA. Effects of Extended-Release Methylphenidate Treatment on Cognitive Task Performance in Children with Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. PMID 32644833 DOI: 10.1089/Cap.2020.0004 |
0.404 |
|
| 2020 |
Johnstone JM, Leung BMY, Srikanth P, Hatsu I, Perez L, Gracious B, Tost G, Aman MG, Gadow KD, Findling RL, Bukstein O, Arnold LE. Development of a Composite Primary Outcome Score for Children with Attention-Deficit/Hyperactivity Disorder and Emotional Dysregulation. Journal of Child and Adolescent Psychopharmacology. PMID 32101469 DOI: 10.1089/Cap.2019.0179 |
0.413 |
|
| 2019 |
Grondhuis SN, Farmer CA, Arnold LE, Gadow KD, Findling RL, Molina BSG, Kolko DJ, Buchan-Page KA, Rice RR, Butter EM, Aman MG. Standardized Observation Analogue Procedure in the Treatment of Severe Childhood Aggression Study. Journal of Child and Adolescent Psychopharmacology. PMID 31730370 DOI: 10.1089/Cap.2019.0109 |
0.392 |
|
| 2019 |
Garfunkel D, Anagnostou EA, Aman MG, Handen BL, Sanders KB, Macklin EA, Chan J, Veenstra-VanderWeele J. Pharmacogenetics of Metformin for Medication-Induced Weight Gain in Autism Spectrum Disorder. Journal of Child and Adolescent Psychopharmacology. PMID 31188026 DOI: 10.1089/Cap.2018.0171 |
0.337 |
|
| 2019 |
Hardan AY, Hendren RL, Aman MG, Robb A, Melmed RD, Andersen KA, Luchini R, Rahman R, Ali S, Jia XD, Mallick M, Lateiner JE, Palmer RH, Graham SM. Efficacy and safety of memantine in children with autism spectrum disorder: Results from three phase 2 multicenter studies. Autism : the International Journal of Research and Practice. 1362361318824103. PMID 31027422 DOI: 10.1177/1362361318824103 |
0.367 |
|
| 2019 |
Bangerter A, Ness S, Lewin D, Aman MG, Esbensen AJ, Goodwin MS, Dawson G, Hendren R, Leventhal B, Shic F, Opler M, Ho KF, Pandina G. Clinical Validation of the Autism Behavior Inventory: Caregiver-Rated Assessment of Core and Associated Symptoms of Autism Spectrum Disorder. Journal of Autism and Developmental Disorders. PMID 30888551 DOI: 10.1007/S10803-019-03965-7 |
0.424 |
|
| 2019 |
Scahill L, Lecavalier L, Schultz RT, Evans AN, Maddox B, Pritchett J, Herrington J, Gillespie S, Miller J, Amoss RT, Aman MG, Bearss K, Gadow K, Edwards MC. Development of the Parent-Rated Anxiety Scale for Youth with Autism Spectrum Disorder. Journal of the American Academy of Child and Adolescent Psychiatry. PMID 30797036 DOI: 10.1016/J.Jaac.2018.10.016 |
0.391 |
|
| 2019 |
Halvorsen M, Aman MG, Mathiassen B, Brøndbo PH, Steinsvik OO, Martinussen M. Psychometric Properties of the Norwegian Aberrant Behavior Checklist and Diagnostic Relationships in a Neuro-pediatric Sample Journal of Mental Health Research in Intellectual Disabilities. 12: 234-255. DOI: 10.1080/19315864.2019.1630872 |
0.362 |
|
| 2019 |
Norris M, Aman MG, Mazurek MO, Scherr JF, Butter EM. Psychometric characteristics of the aberrant behavior checklist in a well-defined sample of youth with autism Spectrum disorder Research in Autism Spectrum Disorders. 62: 1-9. DOI: 10.1016/J.Rasd.2019.02.001 |
0.475 |
|
| 2019 |
Postorino V, Gillespie S, Lecavalier L, Smith T, Johnson C, Swiezy N, Aman MG, McDougle CJ, Bearss K, Andridge RR, Vitiello B, Scahill L. Clinical Correlates of Parenting Stress in Children with Autism Spectrum Disorder and Serious Behavioral Problems Journal of Child and Family Studies. 28: 2069-2077. DOI: 10.1007/S10826-019-01423-7 |
0.44 |
|
| 2018 |
Joseph HM, Farmer C, Kipp H, Kolko D, Aman M, McGinley J, Arnold LE, Gadow KD, Findling RL, Molina BSG. Attendance and Engagement in Parent Training Predict Child Behavioral Outcomes in Children Pharmacologically Treated for Attention-Deficit/Hyperactivity Disorder and Severe Aggression. Journal of Child and Adolescent Psychopharmacology. PMID 30592635 DOI: 10.1089/Cap.2018.0119 |
0.437 |
|
| 2018 |
Lecavalier L, McCracken CE, Aman MG, McDougle CJ, McCracken JT, Tierney E, Smith T, Johnson C, King B, Handen B, Swiezy NB, Eugene Arnold L, Bearss K, Vitiello B, Scahill L. An exploration of concomitant psychiatric disorders in children with autism spectrum disorder. Comprehensive Psychiatry. 88: 57-64. PMID 30504071 DOI: 10.1016/J.Comppsych.2018.10.012 |
0.441 |
|
| 2018 |
Handen BL, Veenstra-VanderWeele J, Anagnostou E, Aman MG. Dr. Handen et al. Reply. Journal of the American Academy of Child and Adolescent Psychiatry. 57: 793-795. PMID 30274655 DOI: 10.1016/J.Jaac.2018.08.005 |
0.429 |
|
| 2018 |
Barrie ES, Pinsonneault JK, Sadee W, Hollway JA, Handen BL, Smith T, Arnold LE, Butter E, Hansen-Kiss E, Herman GE, Aman MG. Testing genetic modifiers of behavior and response to atomoxetine in autism spectrum disorder with ADHD. Journal of Developmental and Physical Disabilities. 30: 355-371. PMID 30197492 DOI: 10.1007/S10882-018-9590-4 |
0.358 |
|
| 2018 |
Arnold LE, Ober N, Aman MG, Handen B, Smith T, Pan X, Hyman SL, Hollway J, Lecavalier L, Page K, Rice R. A 1.5-Year Follow-Up of Parent Training and Atomoxetine for Attention-Deficit/Hyperactivity Disorder Symptoms and Noncompliant/Disruptive Behavior in Autism. Journal of Child and Adolescent Psychopharmacology. PMID 29694241 DOI: 10.1089/Cap.2017.0134 |
0.458 |
|
| 2018 |
Aman MG, Hollway JA, Veenstra-VanderWeele J, Handen BL, Sanders KB, Chan J, Macklin E, Arnold LE, Wong T, Newsom C, Hastie Adams R, Marler S, Peleg N, Anagnostou EA. Effects of Metformin on Spatial and Verbal Memory in Children with ASD and Overweight Associated with Atypical Antipsychotic Use. Journal of Child and Adolescent Psychopharmacology. PMID 29620914 DOI: 10.1089/Cap.2017.0072 |
0.353 |
|
| 2018 |
Grondhuis SN, Lecavalier L, Arnold LE, Handen BL, Scahill L, McDougle CJ, Aman MG. Differences in verbal and nonverbal IQ test scores in children with autism spectrum disorder Research in Autism Spectrum Disorders. 49: 47-55. DOI: 10.1016/J.Rasd.2018.02.001 |
0.431 |
|
| 2017 |
Hollway JA, Mendoza-Burcham M, Andridge R, Aman MG, Handen B, Arnold LE, Lecavalier L, Williams C, Silverman L, Smith T. Atomoxetine, Parent Training, and Their Effects on Sleep in Youth with Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder. Journal of Child and Adolescent Psychopharmacology. PMID 29112459 DOI: 10.1089/Cap.2017.0085 |
0.433 |
|
| 2017 |
Lecavalier L, Pan X, Smith T, Handen BL, Arnold LE, Silverman L, Tumuluru RV, Hollway J, Aman MG. Parent Stress in a Randomized Clinical Trial of Atomoxetine and Parent Training for Children with Autism Spectrum Disorder. Journal of Autism and Developmental Disorders. PMID 29022125 DOI: 10.1007/S10803-017-3345-4 |
0.445 |
|
| 2017 |
Handen BL, Anagnostou E, Aman MG, Sanders KB, Chan J, Hollway JA, Brian J, Arnold LE, Capano L, Williams C, Hellings JA, Butter E, Mankad D, Tumuluru R, Kettel J, et al. A Randomized, Placebo-Controlled Trial of Metformin for the Treatment of Overweight Induced by Antipsychotic Medication in Young People With Autism Spectrum Disorder: Open-Label Extension. Journal of the American Academy of Child and Adolescent Psychiatry. 56: 849-856.e6. PMID 28942807 DOI: 10.1016/J.Jaac.2017.07.790 |
0.411 |
|
| 2017 |
Tumuluru RV, Corbett-Dick P, Aman MG, Smith T, Arnold LE, Pan X, Buchan-Page KA, Brown NV, Ryan MM, Hyman SL, Hellings J, Williams C, Hollway JA, Lecavalier L, Rice RR, et al. Adverse Events of Atomoxetine in a Double-Blind Placebo-Controlled Study in Children with Autism. Journal of Child and Adolescent Psychopharmacology. PMID 28509573 DOI: 10.1089/Cap.2016.0187 |
0.471 |
|
| 2017 |
Criado KK, Sharp WG, McCracken CE, De Vinck-Baroody O, Dong L, Aman MG, McDougle CJ, McCracken JT, Eugene Arnold L, Weitzman C, Leventhal JM, Vitiello B, Scahill L. Overweight and obese status in children with autism spectrum disorder and disruptive behavior. Autism : the International Journal of Research and Practice. 1362361316683888. PMID 28325061 DOI: 10.1177/1362361316683888 |
0.436 |
|
| 2017 |
Findling RL, Townsend L, Brown NV, Arnold LE, Gadow KD, Kolko DJ, McNamara NK, Gary DS, Kaplin DB, Farmer CA, Kipp H, Williams C, Butter EM, Bukstein OG, Rice R, ... ... Aman MG, et al. The Treatment of Severe Childhood Aggression Study: 12 Weeks of Extended, Blinded Treatment in Clinical Responders. Journal of Child and Adolescent Psychopharmacology. 27: 52-65. PMID 28212067 DOI: 10.1089/Cap.2016.0081 |
0.415 |
|
| 2017 |
Bangerter A, Ness S, Lewin D, Aman M, Esbensen A, Goodwin M, Dawson G, Hendren R, Leventhal B, Opler M, Ho KF, Pandina G. 177. Autism Behavior Inventory – A Novel Tool for Assessment of Changes in Core and Associated Symptoms of Autism Spectrum Disorder Biological Psychiatry. 81. DOI: 10.1016/J.Biopsych.2017.02.190 |
0.404 |
|
| 2016 |
Lecavalier L, Smith T, Johnson C, Bearss K, Swiezy N, Aman MG, Sukhodolsky DG, Deng Y, Dziura J, Scahill L. Moderators of Parent Training for Disruptive Behaviors in Young Children with Autism Spectrum Disorder. Journal of Abnormal Child Psychology. PMID 27917460 DOI: 10.1007/S10802-016-0233-X |
0.48 |
|
| 2016 |
Scahill L, Bearss K, Sarhangian R, McDougle CJ, Arnold LE, Aman MG, McCracken JT, Tierney E, Gillespie S, Postorino V, Vitiello B. Using a Patient-Centered Outcome Measure to Test Methylphenidate Versus Placebo in Children with Autism Spectrum Disorder. Journal of Child and Adolescent Psychopharmacology. PMID 27893955 DOI: 10.1089/Cap.2016.0107 |
0.48 |
|
| 2016 |
Vo LC, Snyder C, McCracken C, McDougle CJ, McCracken JT, Aman MG, Tierney E, Arnold LE, Levi D, Kelleman M, Carroll D, Morrissey J, Vitiello B, Scahill L. No Apparent Cardiac Conduction Effects of Acute Treatment with Risperidone in Children with Autism Spectrum Disorder. Journal of Child and Adolescent Psychopharmacology. PMID 27726426 DOI: 10.1089/Cap.2016.0090 |
0.472 |
|
| 2016 |
Smith T, Aman MG, Arnold LE, Silverman LB, Lecavalier L, Hollway J, Tumuluru R, Hyman SL, Buchan-Page KA, Hellings J, Rice RR, Brown NV, Pan X, Handen BL. Atomoxetine and Parent Training for Children With Autism and Attention-Deficit/Hyperactivity Disorder: A 24-Week Extension Study. Journal of the American Academy of Child and Adolescent Psychiatry. 55: 868-876.e2. PMID 27663942 DOI: 10.1016/J.Jaac.2016.06.015 |
0.478 |
|
| 2016 |
Anagnostou E, Aman MG, Handen BL, Sanders KB, Shui A, Hollway JA, Brian J, Arnold LE, Capano L, Hellings JA, Butter E, Mankad D, Tumuluru R, Kettel J, Newsom CR, et al. Metformin for Treatment of Overweight Induced by Atypical Antipsychotic Medication in Young People With Autism Spectrum Disorder: A Randomized Clinical Trial. Jama Psychiatry. PMID 27556593 DOI: 10.1001/Jamapsychiatry.2016.1232 |
0.443 |
|
| 2016 |
Farmer CA, Epstein JN, Findling RL, Gadow KD, Arnold LE, Kipp H, Kolko DJ, Butter E, Schneider J, Bukstein OG, McNamara NK, Molina BS, Aman MG. Risperidone Added to Psychostimulant in Children with Severe Aggression and Attention-Deficit/Hyperactivity Disorder: Lack of Effect on Attention and Short-Term Memory. Journal of Child and Adolescent Psychopharmacology. PMID 27348211 DOI: 10.1089/Cap.2016.0040 |
0.363 |
|
| 2016 |
Scahill L, Bearss K, Lecavalier L, Smith T, Swiezy N, Aman MG, Sukhodolsky DG, McCracken C, Minshawi N, Turner K, Levato L, Saulnier C, Dziura J, Johnson C. Effect of Parent Training on Adaptive Behavior in Children With Autism Spectrum Disorder and Disruptive Behavior: Results of a Randomized Trial. Journal of the American Academy of Child and Adolescent Psychiatry. 55: 602-609.e3. PMID 27343887 DOI: 10.1016/J.Jaac.2016.05.001 |
0.467 |
|
| 2016 |
Johnson CR, DeMand A, Lecavalier L, Smith T, Aman M, Foldes E, Scahill L. Psychometric properties of the children's sleep habits questionnaire in children with autism spectrum disorder. Sleep Medicine. 20: 5-11. PMID 27318219 DOI: 10.1016/J.Sleep.2015.12.005 |
0.405 |
|
| 2016 |
Gadow KD, Brown NV, Arnold LE, Buchan-Page KA, Bukstein OG, Butter E, Farmer CA, Findling RL, Kolko DJ, Molina BS, Rice RR, Schneider J, Aman MG. Severely Aggressive Children Receiving Stimulant Medication Versus Stimulant and Risperidone: 12-Month Follow-Up of the TOSCA Trial. Journal of the American Academy of Child and Adolescent Psychiatry. 55: 469-78. PMID 27238065 DOI: 10.1016/J.Jaac.2016.03.014 |
0.449 |
|
| 2016 |
Scahill L, Jeon S, Boorin SJ, McDougle CJ, Aman MG, Dziura J, McCracken JT, Caprio S, Arnold LE, Nicol G, Deng Y, Challa SA, Vitiello B. Weight Gain and Metabolic Consequences of Risperidone in Young Children With Autism Spectrum Disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 55: 415-23. PMID 27126856 DOI: 10.1016/J.Jaac.2016.02.016 |
0.418 |
|
| 2016 |
Aman MG, Findling RL, Hardan AY, Hendren RL, Melmed RD, Kehinde-Nelson O, Hsu HA, Trugman JM, Palmer RH, Graham SM, Gage AT, Perhach JL, Katz E. Safety and Efficacy of Memantine in Children with Autism: Randomized, Placebo-Controlled Study and Open-Label Extension. Journal of Child and Adolescent Psychopharmacology. PMID 26978327 DOI: 10.1089/Cap.2015.0146 |
0.443 |
|
| 2016 |
Hollway JA, Aman MG, Mendoza-Burcham MI, Silverman L, Arnold LE, Tumuluru R, Handen BL, Lecavalier L, Page K, Sayre P, Smith T. Caregiver Satisfaction with a Multisite Trial of Atomoxetine and Parent Training for Attention-Deficit/Hyperactivity Disorder and Behavioral Noncompliance in Children with Autism Spectrum Disorder. Journal of Child and Adolescent Psychopharmacology. PMID 26797318 DOI: 10.1089/Cap.2015.0130 |
0.356 |
|
| 2016 |
Farmer CA, Kaat AJ, Mazurek MO, Lainhart JE, DeWitt MB, Cook EH, Butter EM, Aman MG. Confirmation of the Factor Structure and Measurement Invariance of the Children's Scale of Hostility and Aggression: Reactive/Proactive in Clinic-Referred Children with and without Autism Spectrum Disorder. Journal of Child and Adolescent Psychopharmacology. PMID 26744772 DOI: 10.1089/Cap.2015.0098 |
0.442 |
|
| 2016 |
Johnson CR, DeMand A, Lecavalier L, Smith T, Aman M, Foldes E, Scahill L. Psychometric properties of the children's sleep habits questionnaire in children with autism spectrum disorder Sleep Medicine. 20: 5-11. DOI: 10.1016/j.sleep.2015.12.005 |
0.302 |
|
| 2016 |
Bangerter A, Ness S, Ho KF, Aman MG, Esbensen A, Goodwin MS, Dawson G, Hendren RL, Leventhal BL, Opler M, Pandina GJ. 1.29 THE AUTISM BEHAVIOR INVENTORY: A NOVEL TOOL FOR ASSESSING CHANGE IN CORE AND ASSOCIATED SYMPTOMS OF AUTISM SPECTRUM DISORDER Journal of the American Academy of Child & Adolescent Psychiatry. 55: S109. DOI: 10.1016/J.Jaac.2016.09.030 |
0.406 |
|
| 2016 |
Grondhuis SN, Aman MG. Risk Factors for Overweight in Children with Autism Spectrum Disorder Journal of Developmental and Physical Disabilities. 29: 241-263. DOI: 10.1007/S10882-016-9522-0 |
0.451 |
|
| 2015 |
Handen BL, Aman MG, Arnold LE, Hyman SL, Tumuluru RV, Lecavalier L, Corbett-Dick P, Pan X, Hollway JA, Buchan-Page KA, Silverman LB, Brown NV, Rice RR, Hellings J, Mruzek DW, et al. Atomoxetine, Parent Training, and Their Combination in Children With Autism Spectrum Disorder and Attention-Deficit/Hyperactivity Disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 54: 905-15. PMID 26506581 DOI: 10.1016/J.Jaac.2015.08.013 |
0.467 |
|
| 2015 |
Kaat A, Farmer C, Gadow K, Findling RL, Bukstein O, Arnold LE, Bangalore S, McNamara N, Aman M. Factor Validity of a Proactive and Reactive Aggression Rating Scale. Journal of Child and Family Studies. 24: 2734-2744. PMID 26504369 DOI: 10.1007/S10826-014-0075-5 |
0.43 |
|
| 2015 |
Bearss K, Taylor CA, Aman MG, Whittemore R, Lecavalier L, Miller J, Pritchett J, Green B, Scahill L. Using qualitative methods to guide scale development for anxiety in youth with autism spectrum disorder. Autism : the International Journal of Research and Practice. PMID 26395234 DOI: 10.1177/1362361315601012 |
0.452 |
|
| 2015 |
Aman M, Rettiganti M, Nagaraja HN, Hollway JA, McCracken J, McDougle CJ, Tierney E, Scahill L, Arnold LE, Hellings J, Posey DJ, Swiezy NB, Ghuman J, Grados M, Shah B, et al. Tolerability, Safety, and Benefits of Risperidone in Children and Adolescents with Autism: 21-Month Follow-up After 8-Week Placebo-Controlled Trial. Journal of Child and Adolescent Psychopharmacology. 25: 482-93. PMID 26262903 DOI: 10.1089/Cap.2015.0005 |
0.363 |
|
| 2015 |
Chowdhury M, Aman MG, Lecavalier L, Smith T, Johnson C, Swiezy N, McCracken JT, King B, McDougle CJ, Bearss K, Deng Y, Scahill L. Factor structure and psychometric properties of the revised Home Situations Questionnaire for autism spectrum disorder: The Home Situations Questionnaire-Autism Spectrum Disorder. Autism : the International Journal of Research and Practice. PMID 26187059 DOI: 10.1177/1362361315593941 |
0.488 |
|
| 2015 |
Aman MG, Arnold LE, Hollway JA. Assessing change in core autism symptoms: challenges for pharmacological studies. Journal of Child and Adolescent Psychopharmacology. 25: 282-5. PMID 25978740 DOI: 10.1089/Cap.2015.28999.Mga |
0.451 |
|
| 2015 |
Bearss K, Johnson C, Smith T, Lecavalier L, Swiezy N, Aman M, McAdam DB, Butter E, Stillitano C, Minshawi N, Sukhodolsky DG, Mruzek DW, Turner K, Neal T, Hallett V, et al. Effect of parent training vs parent education on behavioral problems in children with autism spectrum disorder: a randomized clinical trial. Jama. 313: 1524-33. PMID 25898050 DOI: 10.1001/Jama.2015.3150 |
0.483 |
|
| 2015 |
Rundberg-Rivera EV, Townsend LD, Schneider J, Farmer CA, Molina BB, Findling RL, Gadow KD, Bukstein OG, Arnold LE, Kolko DJ, Buchan-Page KA, McNamara NK, Michel C, Austin A, Kipp H, ... ... Aman MG, et al. Participant satisfaction in a study of stimulant, parent training, and risperidone in children with severe physical aggression. Journal of Child and Adolescent Psychopharmacology. 25: 225-33. PMID 25885012 DOI: 10.1089/Cap.2014.0097 |
0.379 |
|
| 2015 |
Farmer CA, Brown NV, Gadow KD, Arnold LE, Kolko DG, Findling RL, Molina BS, Buchan-Page KA, Rice RR, Bangalore SS, Bukstein O, Rundberg-Rivera EV, McNamara N, Aman MG. Comorbid symptomatology moderates response to risperidone, stimulant, and parent training in children with severe aggression, disruptive behavior disorder, and attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology. 25: 213-24. PMID 25885011 DOI: 10.1089/Cap.2014.0109 |
0.459 |
|
| 2015 |
Arnold LE, Gadow KD, Farmer CA, Findling RL, Bukstein O, Molina BS, Brown NV, Li X, Rundberg-Rivera EV, Bangalore S, Buchan-Page K, Hurt EA, Rice R, McNamara NK, Aman MG. Comorbid anxiety and social avoidance in treatment of severe childhood aggression: response to adding risperidone to stimulant and parent training; mediation of disruptive symptom response. Journal of Child and Adolescent Psychopharmacology. 25: 203-12. PMID 25885010 DOI: 10.1089/Cap.2014.0104 |
0.404 |
|
| 2015 |
Aman MG. Treatment of Severe Childhood Aggression (TOSCA) Studies. Journal of Child and Adolescent Psychopharmacology. 25: 201-2. PMID 25885009 DOI: 10.1089/Cap.2015.2532 |
0.426 |
|
| 2015 |
Scahill L, Sukhodolsky DG, Anderberg E, Dimitropoulos A, Dziura J, Aman MG, McCracken J, Tierney E, Hallett V, Katz K, Vitiello B, McDougle C. Sensitivity of the modified Children's Yale-Brown Obsessive Compulsive Scale to detect change: Results from two multi-site trials. Autism : the International Journal of Research and Practice. PMID 25882391 DOI: 10.1177/1362361315574889 |
0.475 |
|
| 2015 |
Hellings JA, Reed G, Cain SE, Zhou X, Barth FX, Aman MG, Palaguachi GI, Mikhnev D, Teng R, Andridge R, Logan M, Butler MG, Han JC. Loxapine add-on for adolescents and adults with autism spectrum disorders and irritability. Journal of Child and Adolescent Psychopharmacology. 25: 150-9. PMID 25782098 DOI: 10.1089/Cap.2014.0003 |
0.349 |
|
| 2015 |
Farmer C, Butter E, Mazurek MO, Cowan C, Lainhart J, Cook EH, DeWitt MB, Aman M. Aggression in children with autism spectrum disorders and a clinic-referred comparison group. Autism : the International Journal of Research and Practice. 19: 281-91. PMID 24497627 DOI: 10.1177/1362361313518995 |
0.5 |
|
| 2015 |
Scahill L, Aman MG, Lecavalier L, Halladay AK, Bishop SL, Bodfish JW, Grondhuis S, Jones N, Horrigan JP, Cook EH, Handen BL, King BH, Pearson DA, McCracken JT, Sullivan KA, et al. Measuring repetitive behaviors as a treatment endpoint in youth with autism spectrum disorder. Autism : the International Journal of Research and Practice. 19: 38-52. PMID 24259748 DOI: 10.1177/1362361313510069 |
0.432 |
|
| 2014 |
Silverman L, Hollway JA, Smith T, Aman MG, Arnold LE, Pan X, Li X, Handen BL. A Multisite Trial of Atomoxetine and Parent Training in Children with Autism Spectrum Disorders: Rationale and Design Challenges. Research in Autism Spectrum Disorders. 8: 899-907. PMID 25197320 DOI: 10.1016/J.Rasd.2014.03.013 |
0.496 |
|
| 2014 |
Matlock ST, Aman MG. Psychometric characteristics of the adult scale of hostility and aggression: reactive/proactive (A-SHARP) and relation to psychiatric features of adults with developmental disabilities. Research in Developmental Disabilities. 35: 3199-207. PMID 25155742 DOI: 10.1016/J.Ridd.2014.07.029 |
0.359 |
|
| 2014 |
Gadow KD, Arnold LE, Molina BS, Findling RL, Bukstein OG, Brown NV, McNamara NK, Rundberg-Rivera EV, Li X, Kipp HL, Schneider J, Farmer CA, Baker JL, Sprafkin J, Rice RR, ... ... Aman MG, et al. Risperidone added to parent training and stimulant medication: effects on attention-deficit/hyperactivity disorder, oppositional defiant disorder, conduct disorder, and peer aggression. Journal of the American Academy of Child and Adolescent Psychiatry. 53: 948-959.e1. PMID 25151418 DOI: 10.1016/J.Jaac.2014.05.008 |
0.405 |
|
| 2014 |
Aman MG, Smith T, Arnold LE, Corbett-Dick P, Tumuluru R, Hollway JA, Hyman SL, Mendoza-Burcham M, Pan X, Mruzek DW, Lecavalier L, Levato L, Silverman LB, Handen B. A review of atomoxetine effects in young people with developmental disabilities. Research in Developmental Disabilities. 35: 1412-24. PMID 24732041 DOI: 10.1016/J.Ridd.2014.03.006 |
0.455 |
|
| 2014 |
Scahill L, Dimitropoulos A, McDougle CJ, Aman MG, Feurer ID, McCracken JT, Tierney E, Pu J, White S, Lecavalier L, Hallett V, Bearss K, King B, Arnold LE, Vitiello B. Children's Yale-Brown obsessive compulsive scale in autism spectrum disorder: component structure and correlates of symptom checklist. Journal of the American Academy of Child and Adolescent Psychiatry. 53: 97-107.e1. PMID 24342389 DOI: 10.1016/J.Jaac.2013.09.018 |
0.476 |
|
| 2014 |
Aman MG, Bukstein OG, Gadow KD, Arnold LE, Molina BS, McNamara NK, Rundberg-Rivera EV, Li X, Kipp H, Schneider J, Butter EM, Baker J, Sprafkin J, Rice RR, Bangalore SS, et al. What does risperidone add to parent training and stimulant for severe aggression in child attention-deficit/hyperactivity disorder? Journal of the American Academy of Child and Adolescent Psychiatry. 53: 47-60.e1. PMID 24342385 DOI: 10.1016/J.Jaac.2013.09.022 |
0.412 |
|
| 2014 |
Carroll D, Hallett V, McDougle CJ, Aman MG, McCracken JT, Tierney E, Arnold LE, Sukhodolsky DG, Lecavalier L, Handen BL, Swiezy N, Johnson C, Bearss K, Vitiello B, Scahill L. Examination of aggression and self-injury in children with autism spectrum disorders and serious behavioral problems. Child and Adolescent Psychiatric Clinics of North America. 23: 57-72. PMID 24231167 DOI: 10.1016/J.Chc.2013.08.002 |
0.478 |
|
| 2014 |
Kaat AJ, Lecavalier L, Aman MG. Validity of the aberrant behavior checklist in children with autism spectrum disorder. Journal of Autism and Developmental Disorders. 44: 1103-16. PMID 24165702 DOI: 10.1007/S10803-013-1970-0 |
0.483 |
|
| 2014 |
Lecavalier L, Wood JJ, Halladay AK, Jones NE, Aman MG, Cook EH, Handen BL, King BH, Pearson DA, Hallett V, Sullivan KA, Grondhuis S, Bishop SL, Horrigan JP, Dawson G, et al. Measuring anxiety as a treatment endpoint in youth with autism spectrum disorder. Journal of Autism and Developmental Disorders. 44: 1128-43. PMID 24158679 DOI: 10.1007/S10803-013-1974-9 |
0.386 |
|
| 2014 |
Grondhuis SN, Aman MG. Overweight and obesity in youth with developmental disabilities: a call to action. Journal of Intellectual Disability Research : Jidr. 58: 787-99. PMID 24020517 DOI: 10.1111/Jir.12090 |
0.31 |
|
| 2014 |
McCracken JT, Badashova KK, Posey DJ, Aman MG, Scahill L, Tierney E, Arnold LE, Vitiello B, Whelan F, Chuang SZ, Davies M, Shah B, McDougle CJ, Nurmi EL. Positive effects of methylphenidate on hyperactivity are moderated by monoaminergic gene variants in children with autism spectrum disorders Pharmacogenomics Journal. 14: 295-302. PMID 23856854 DOI: 10.1038/Tpj.2013.23 |
0.445 |
|
| 2013 |
Nurmi EL, Spilman SL, Whelan F, Scahill LL, Aman MG, McDougle CJ, Arnold LE, Handen B, Johnson C, Sukhodolsky DG, Posey DJ, Lecavalier L, Stigler KA, Ritz L, Tierney E, et al. Moderation of antipsychotic-induced weight gain by energy balance gene variants in the RUPP autism network risperidone studies Translational Psychiatry. 3. PMID 23799528 DOI: 10.1038/Tp.2013.26 |
0.346 |
|
| 2013 |
Pearson DA, Santos CW, Aman MG, Arnold LE, Casat CD, Mansour R, Lane DM, Loveland KA, Bukstein OG, Jerger SW, Factor P, Vanwoerden S, Perez E, Cleveland LA. Effects of extended release methylphenidate treatment on ratings of attention-deficit/hyperactivity disorder (ADHD) and associated behavior in children with autism spectrum disorders and ADHD symptoms. Journal of Child and Adolescent Psychopharmacology. 23: 337-51. PMID 23782128 DOI: 10.1089/Cap.2012.0096 |
0.434 |
|
| 2013 |
Bearss K, Lecavalier L, Minshawi N, Johnson C, Smith T, Handen B, Sukhodolsky D, Aman M, Swiezy N, Butter E, Scahill L. Toward an exportable parent training program for disruptive behaviors in autism spectrum disorders. Neuropsychiatry. 3: 169-180. PMID 23772233 DOI: 10.2217/npy.13.14 |
0.375 |
|
| 2013 |
Handen BL, Johnson CR, Butter EM, Lecavalier L, Scahill L, Aman MG, McDougle CJ, Arnold LE, Swiezy NB, Sukhodolsky DG, Mulick JA, White SW, Bearss K, Hollway JA, Stigler KA, et al. Use of a Direct Observational Measure in a Trial of Risperidone and Parent Training in Children with Pervasive Developmental Disorders. Journal of Developmental and Physical Disabilities. 25: 355-371. PMID 23730123 DOI: 10.1007/S10882-012-9316-Y |
0.388 |
|
| 2013 |
Hollway JA, Aman MG, Butter E. Correlates and risk markers for sleep disturbance in participants of the Autism Treatment Network. Journal of Autism and Developmental Disorders. 43: 2830-43. PMID 23624832 DOI: 10.1007/S10803-013-1830-Y |
0.361 |
|
| 2013 |
Hallett V, Lecavalier L, Sukhodolsky DG, Cipriano N, Aman MG, McCracken JT, McDougle CJ, Tierney E, King BH, Hollander E, Sikich L, Bregman J, Anagnostou E, Donnelly C, Katsovich L, et al. Exploring the manifestations of anxiety in children with autism spectrum disorders. Journal of Autism and Developmental Disorders. 43: 2341-52. PMID 23400347 DOI: 10.1007/S10803-013-1775-1 |
0.427 |
|
| 2013 |
Arnold LE, Anand R, Aman M. Varenicline in autistic disorder: hypothesis and case report of single-patient crossover. Journal of Child and Adolescent Psychopharmacology. 23: 61-4. PMID 23350866 DOI: 10.1089/Cap.2012.0025 |
0.307 |
|
| 2013 |
Kent JM, Kushner S, Ning X, Karcher K, Ness S, Aman M, Singh J, Hough D. Risperidone dosing in children and adolescents with autistic disorder: a double-blind, placebo-controlled study. Journal of Autism and Developmental Disorders. 43: 1773-83. PMID 23212807 DOI: 10.1007/S10803-012-1723-5 |
0.351 |
|
| 2013 |
Scahill L, Hallett V, Aman MG, McDougle CJ, Eugene Arnold L, McCracken JT, Tierney E, Deng Y, Dziura J, Vitiello B. Brief Report: social disability in autism spectrum disorder: results from Research Units on Pediatric Psychopharmacology (RUPP) Autism Network trials. Journal of Autism and Developmental Disorders. 43: 739-46. PMID 23104617 DOI: 10.1007/S10803-012-1689-3 |
0.372 |
|
| 2013 |
Farmer CA, Aman MG. Pharmacological Intervention for Disruptive Behaviors in Intellectual and Developmental Disabilities: The Glass is Half Full International Review of Research in Developmental Disabilities. 44: 281-325. DOI: 10.1016/B978-0-12-401662-0.00009-9 |
0.437 |
|
| 2012 |
Arnold LE, Aman MG, Li X, Butter E, Humphries K, Scahill L, Lecavalier L, McDougle CJ, Swiezy NB, Handen B, Wilson K, Stigler KA. Research Units of Pediatric Psychopharmacology (RUPP) autism network randomized clinical trial of parent training and medication: one-year follow-up. Journal of the American Academy of Child and Adolescent Psychiatry. 51: 1173-84. PMID 23101743 DOI: 10.1016/J.Jaac.2012.08.028 |
0.408 |
|
| 2012 |
Pearson DA, Aman MG, Arnold LE, Lane DM, Loveland KA, Santos CW, Casat CD, Mansour R, Jerger SW, Ezzell S, Factor P, Vanwoerden S, Ye E, Narain P, Cleveland LA. High concordance of parent and teacher attention-deficit/hyperactivity disorder ratings in medicated and unmedicated children with autism spectrum disorders. Journal of Child and Adolescent Psychopharmacology. 22: 284-91. PMID 22849541 DOI: 10.1089/Cap.2011.0067 |
0.465 |
|
| 2012 |
Arnold LE, Aman MG, Hollway J, Hurt E, Bates B, Li X, Farmer C, Anand R, Thompson S, Ramadan Y, Williams C. Placebo-controlled pilot trial of mecamylamine for treatment of autism spectrum disorders. Journal of Child and Adolescent Psychopharmacology. 22: 198-205. PMID 22537359 DOI: 10.1089/Cap.2011.0056 |
0.311 |
|
| 2012 |
Scahill L, McDougle CJ, Aman MG, Johnson C, Handen B, Bearss K, Dziura J, Butter E, Swiezy NG, Arnold LE, Stigler KA, Sukhodolsky DD, Lecavalier L, Pozdol SL, Nikolov R, et al. Effects of risperidone and parent training on adaptive functioning in children with pervasive developmental disorders and serious behavioral problems. Journal of the American Academy of Child and Adolescent Psychiatry. 51: 136-46. PMID 22265360 DOI: 10.1016/J.Jaac.2011.11.010 |
0.478 |
|
| 2012 |
Farmer C, Lecavalier L, Yu S, Eugene Arnold L, McDougle CJ, Scahill L, Handen B, Johnson CR, Stigler KA, Bearss K, Swiezy NB, Aman MG. Predictors and moderators of parent training efficacy in a sample of children with autism spectrum disorders and serious behavioral problems. Journal of Autism and Developmental Disorders. 42: 1037-44. PMID 21822762 DOI: 10.1007/S10803-011-1338-2 |
0.485 |
|
| 2012 |
Aman MG. Aberrant Behavior Checklist: Current Identity and Future Developments Clinical and Experimental Pharmacology. 2. DOI: 10.4172/2161-1459.1000E114 |
0.364 |
|
| 2012 |
Grondhuis SN, Aman MG. Assessment of anxiety in children and adolescents with autism spectrum disorders Research in Autism Spectrum Disorders. 6: 1345-1365. DOI: 10.1016/J.Rasd.2012.04.006 |
0.468 |
|
| 2011 |
Farmer CA, Arnold LE, Bukstein OG, Findling RL, Gadow KD, Li X, Butter EM, Aman MG. The treatment of severe child aggression (TOSCA) study: Design challenges. Child and Adolescent Psychiatry and Mental Health. 5: 36. PMID 22074813 DOI: 10.1186/1753-2000-5-36 |
0.353 |
|
| 2011 |
Tobiasova Z, van der Lingen KH, Scahill L, Leckman JF, Zhang Y, Chae W, McCracken JT, McDougle CJ, Vitiello B, Tierney E, Aman MG, Arnold LE, Katsovich L, Hoekstra PJ, Volkmar F, et al. Risperidone-related improvement of irritability in children with autism is not associated with changes in serum of epidermal growth factor and interleukin-13. Journal of Child and Adolescent Psychopharmacology. 21: 555-64. PMID 22070180 DOI: 10.1089/Cap.2010.0134 |
0.31 |
|
| 2011 |
Marcus RN, Owen R, Manos G, Mankoski R, Kamen L, McQuade RD, Carson WH, Corey-Lisle PK, Aman MG. Aripiprazole in the treatment of irritability in pediatric patients (aged 6-17 years) with autistic disorder: results from a 52-week, open-label study. Journal of Child and Adolescent Psychopharmacology. 21: 229-36. PMID 21663425 DOI: 10.1089/Cap.2009.0121 |
0.402 |
|
| 2011 |
Hollway JA, Aman MG. Sleep correlates of pervasive developmental disorders: a review of the literature. Research in Developmental Disabilities. 32: 1399-421. PMID 21570809 DOI: 10.1016/J.Ridd.2011.04.001 |
0.343 |
|
| 2011 |
Matlock ST, Aman MG. Development of the Adult Scale of Hostility and Aggression: Reactive-Proactive (A-SHARP). American Journal On Intellectual and Developmental Disabilities. 116: 130-41. PMID 21381948 DOI: 10.1352/1944-7558-116.2.130 |
0.317 |
|
| 2011 |
Hollway JA, Aman MG. Pharmacological treatment of sleep disturbance in developmental disabilities: a review of the literature. Research in Developmental Disabilities. 32: 939-62. PMID 21296553 DOI: 10.1016/J.Ridd.2010.12.035 |
0.34 |
|
| 2011 |
Farmer CA, Aman MG. Aripiprazole for the treatment of irritability associated with autism. Expert Opinion On Pharmacotherapy. 12: 635-40. PMID 21294670 DOI: 10.1517/14656566.2011.557661 |
0.449 |
|
| 2011 |
Farmer CA, Aman MG. Aggressive behavior in a sample of children with autism spectrum disorders Research in Autism Spectrum Disorders. 5: 317-323. DOI: 10.1016/J.Rasd.2010.04.014 |
0.496 |
|
| 2010 |
Aman MG, Kasper W, Manos G, Mathew S, Marcus R, Owen R, Mankoski R. Line-item analysis of the Aberrant Behavior Checklist: results from two studies of aripiprazole in the treatment of irritability associated with autistic disorder. Journal of Child and Adolescent Psychopharmacology. 20: 415-22. PMID 20973712 DOI: 10.1089/Cap.2009.0120 |
0.371 |
|
| 2010 |
Reid JM, Storch EA, Murphy TK, Bodzin D, Mutch PJ, Lehmkuhl H, Aman M, Goodman WK. Development and Psychometric Evaluation of the Treatment-Emergent Activation and Suicidality Assessment Profile. Child & Youth Care Forum. 39: 113-124. PMID 20473344 DOI: 10.1007/S10566-010-9095-5 |
0.395 |
|
| 2010 |
Arnold LE, Farmer C, Kraemer HC, Davies M, Witwer A, Chuang S, DiSilvestro R, McDougle CJ, McCracken J, Vitiello B, Aman MG, Scahill L, Posey DJ, Swiezy NB. Moderators, mediators, and other predictors of risperidone response in children with autistic disorder and irritability. Journal of Child and Adolescent Psychopharmacology. 20: 83-93. PMID 20415603 DOI: 10.1089/Cap.2009.0022 |
0.418 |
|
| 2010 |
Chowdhury M, Aman MG, Scahill L, Swiezy N, Arnold LE, Lecavalier L, Johnson C, Handen B, Stigler K, Bearss K, Sukhodolsky D, McDougle CJ. The Home Situations Questionnaire-PDD version: factor structure and psychometric properties. Journal of Intellectual Disability Research : Jidr. 54: 281-91. PMID 20377705 DOI: 10.1111/J.1365-2788.2010.01259.X |
0.445 |
|
| 2010 |
McCracken JT, Aman MG, McDougle CJ, Tierney E, Shiraga S, Whelan F, Arnold LE, Posey D, Ritz L, Vitiello B, Scahill L. Possible influence of variant of the P-glycoprotein gene (MDR1/ABCB1) on clinical response to guanfacine in children with pervasive developmental disorders and hyperactivity. Journal of Child and Adolescent Psychopharmacology. 20: 1-5. PMID 20166790 DOI: 10.1089/cap.2009.0059 |
0.357 |
|
| 2010 |
Farmer CA, Aman MG. Psychometric properties of the Children's Scale of Hostility and Aggression: Reactive/Proactive (C-SHARP). Research in Developmental Disabilities. 31: 270-80. PMID 19854027 DOI: 10.1016/J.Ridd.2009.09.014 |
0.466 |
|
| 2009 |
Aman MG, McDougle CJ, Scahill L, Handen B, Arnold LE, Johnson C, Stigler KA, Bearss K, Butter E, Swiezy NB, Sukhodolsky DD, Ramadan Y, Pozdol SL, Nikolov R, Lecavalier L, et al. Medication and parent training in children with pervasive developmental disorders and serious behavior problems: results from a randomized clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry. 48: 1143-54. PMID 19858761 DOI: 10.1097/Chi.0B013E3181Bfd669 |
0.482 |
|
| 2009 |
Marcus RN, Owen R, Kamen L, Manos G, McQuade RD, Carson WH, Aman MG. A placebo-controlled, fixed-dose study of aripiprazole in children and adolescents with irritability associated with autistic disorder. Journal of the American Academy of Child and Adolescent Psychiatry. 48: 1110-9. PMID 19797985 DOI: 10.1097/Chi.0B013E3181B76658 |
0.456 |
|
| 2009 |
Ghuman JK, Aman MG, Lecavalier L, Riddle MA, Gelenberg A, Wright R, Rice S, Ghuman HS, Fort C. Randomized, placebo-controlled, crossover study of methylphenidate for attention-deficit/hyperactivity disorder symptoms in preschoolers with developmental disorders. Journal of Child and Adolescent Psychopharmacology. 19: 329-39. PMID 19702485 DOI: 10.1089/Cap.2008.0137 |
0.401 |
|
| 2009 |
Johnson CR, Butter EM, Handen BL, Sukhodolsky DG, Mulick J, Lecavalier L, Aman MG, Arnold LE, Scahill L, Swiezy N, Sacco K, Stigler KA, McDougle CJ. Standardised Observation Analogue Procedure (SOAP) for assessing parent and child behaviours in clinical trials. Journal of Intellectual & Developmental Disability. 34: 230-8. PMID 19681003 DOI: 10.1080/13668250903074471 |
0.377 |
|
| 2009 |
Farmer CA, Aman MG. Development of the Children's Scale of Hostility and Aggression: Reactive/Proactive (C-SHARP). Research in Developmental Disabilities. 30: 1155-67. PMID 19375274 DOI: 10.1016/J.Ridd.2009.03.001 |
0.419 |
|
| 2009 |
Ghuman JK, Aman MG, Ghuman HS, Reichenbacher T, Gelenberg A, Wright R, Rice S, Fort C. Prospective, naturalistic, pilot study of open-label atomoxetine treatment in preschool children with attention-deficit/hyperactivity disorder. Journal of Child and Adolescent Psychopharmacology. 19: 155-66. PMID 19364293 DOI: 10.1089/Cap.2008.054 |
0.458 |
|
| 2009 |
Handen BL, Melmed RD, Hansen RL, Aman MG, Burnham DL, Bruss JB, McDougle CJ. A double-blind, placebo-controlled trial of oral human immunoglobulin for gastrointestinal dysfunction in children with autistic disorder. Journal of Autism and Developmental Disorders. 39: 796-805. PMID 19148734 DOI: 10.1007/S10803-008-0687-Y |
0.447 |
|
| 2009 |
Scahill L, Aman MG, McDougle CJ, Arnold LE, McCracken JT, Handen B, Johnson C, Dziura J, Butter E, Sukhodolsky D, Swiezy N, Mulick J, Stigler K, Bearss K, Ritz L, et al. Trial design challenges when combining medication and parent training in children with pervasive developmental disorders. Journal of Autism and Developmental Disorders. 39: 720-9. PMID 19096921 DOI: 10.1007/S10803-008-0675-2 |
0.37 |
|
| 2009 |
Nikolov RN, Bearss KE, Lettinga J, Erickson C, Rodowski M, Aman MG, McCracken JT, McDougle CJ, Tierney E, Vitiello B, Arnold LE, Shah B, Posey DJ, Ritz L, Scahill L. Gastrointestinal symptoms in a sample of children with pervasive developmental disorders. Journal of Autism and Developmental Disorders. 39: 405-13. PMID 18791817 DOI: 10.1007/S10803-008-0637-8 |
0.43 |
|
| 2009 |
Aman MG, Hollway JA, Leone S, Masty J, Lindsay R, Nash P, Arnold LE. Effects of risperidone on cognitive-motor performance and motor movements in chronically medicated children. Research in Developmental Disabilities. 30: 386-96. PMID 18768293 DOI: 10.1016/J.Ridd.2008.07.004 |
0.353 |
|
| 2009 |
Jahromi LB, Kasari CL, McCracken JT, Lee LS, Aman MG, McDougle CJ, Scahill L, Tierney E, Arnold LE, Vitiello B, Ritz L, Witwer A, Kustan E, Ghuman J, Posey DJ. Positive effects of methylphenidate on social communication and self-regulation in children with pervasive developmental disorders and hyperactivity. Journal of Autism and Developmental Disorders. 39: 395-404. PMID 18752063 DOI: 10.1007/S10803-008-0636-9 |
0.442 |
|
| 2009 |
Karabekiroglu K, Aman MG. Validity of the aberrant behavior checklist in a clinical sample of toddlers. Child Psychiatry and Human Development. 40: 99-110. PMID 18600444 DOI: 10.1007/S10578-008-0108-7 |
0.475 |
|
| 2008 |
Aman MG, Farmer CA. Psychotropic medication research in children and adolescents: empirical findings and ethical implications. Journal of Empirical Research On Human Research Ethics : Jerhre. 3: 39-47. PMID 19385769 DOI: 10.1525/Jer.2008.3.3.39 |
0.405 |
|
| 2008 |
Aman MG, Farmer CA, Hollway J, Arnold LE. Treatment of inattention, overactivity, and impulsiveness in autism spectrum disorders. Child and Adolescent Psychiatric Clinics of North America. 17: 713-38, vii. PMID 18775366 DOI: 10.1016/J.Chc.2008.06.009 |
0.392 |
|
| 2008 |
Scahill L, Aman MG, McCracken JT, McDougle CJ, Vitiello B. Beware of over-interpreting negative trials. Journal of Autism and Developmental Disorders. 38: 1609-10. PMID 18594960 DOI: 10.1007/S10803-008-0581-7 |
0.351 |
|
| 2008 |
Aman MG, Hollway JA, McDougle CJ, Scahill L, Tierney E, McCracken JT, Arnold LE, Vitiello B, Ritz L, Gavaletz A, Cronin P, Swiezy N, Wheeler C, Koenig K, Ghuman JK, et al. Cognitive effects of risperidone in children with autism and irritable behavior. Journal of Child and Adolescent Psychopharmacology. 18: 227-36. PMID 18582177 DOI: 10.1089/Cap.2007.0133 |
0.407 |
|
| 2008 |
Aman M, Leone S, Lecavalier L, Park L, Buican B, Coury D. The Nisonger Child Behavior Rating Form: typical IQ version. International Clinical Psychopharmacology. 23: 232-42. PMID 18545062 DOI: 10.1097/Yic.0B013E3282F94Ad0 |
0.478 |
|
| 2008 |
Sukhodolsky DG, Scahill L, Gadow KD, Arnold LE, Aman MG, McDougle CJ, McCracken JT, Tierney E, Williams White S, Lecavalier L, Vitiello B. Parent-rated anxiety symptoms in children with pervasive developmental disorders: frequency and association with core autism symptoms and cognitive functioning. Journal of Abnormal Child Psychology. 36: 117-28. PMID 17674186 DOI: 10.1007/S10802-007-9165-9 |
0.473 |
|
| 2008 |
Field CJ, Aman MG, White AJ, Vaithianathan C. A single-subject study of imipramine in a mentally retarded woman with depressive symptoms. Journal of Intellectual Disability Research. 30: 191-198. PMID 3735414 DOI: 10.1111/J.1365-2788.1986.Tb01312.X |
0.327 |
|
| 2007 |
Jensen PS, Youngstrom EA, Steiner H, Findling RL, Meyer RE, Malone RP, Carlson GA, Coccaro EF, Aman MG, Blair J, Dougherty D, Ferris C, Flynn L, Green E, Hoagwood K, et al. Consensus report on impulsive aggression as a symptom across diagnostic categories in child psychiatry: implications for medication studies. Journal of the American Academy of Child and Adolescent Psychiatry. 46: 309-22. PMID 17314717 DOI: 10.1097/Chi.0B013E31802F1454 |
0.364 |
|
| 2007 |
Posey DJ, Aman MG, McCracken JT, Scahill L, Tierney E, Arnold LE, Vitiello B, Chuang SZ, Davies M, Ramadan Y, Witwer AN, Swiezy NB, Cronin P, Shah B, Carroll DH, et al. Positive effects of methylphenidate on inattention and hyperactivity in pervasive developmental disorders: an analysis of secondary measures. Biological Psychiatry. 61: 538-44. PMID 17276750 DOI: 10.1016/J.Biopsych.2006.09.028 |
0.427 |
|
| 2007 |
Wagner A, Lecavalier L, Arnold LE, Aman MG, Scahill L, Stigler KA, Johnson CR, McDougle CJ, Vitiello B. Developmental disabilities modification of the Children's Global Assessment Scale. Biological Psychiatry. 61: 504-11. PMID 17276748 DOI: 10.1016/J.Biopsych.2007.01.001 |
0.431 |
|
| 2007 |
Pandina GJ, Bilder R, Harvey PD, Keefe RSE, Aman MG, Gharabawi G. Risperidone and Cognitive Function in Children With Disruptive Behavior Disorders Biological Psychiatry. 62: 226-234. PMID 17210137 DOI: 10.1016/J.Biopsych.2006.09.036 |
0.439 |
|
| 2007 |
Tierney E, Aman M, Stout D, Pappas K, Arnold LE, Vitiello B, Scahill L, McDougle C, McCracken J, Wheeler C, Martin A, Posey D, Shah B. Parent satisfaction in a multi-site acute trial of risperidone in children with autism: a social validity study. Psychopharmacology. 191: 149-57. PMID 17123125 DOI: 10.1007/S00213-006-0604-Z |
0.366 |
|
| 2007 |
Lam KS, Aman MG. The Repetitive Behavior Scale-Revised: independent validation in individuals with autism spectrum disorders. Journal of Autism and Developmental Disorders. 37: 855-66. PMID 17048092 DOI: 10.1007/S10803-006-0213-Z |
0.387 |
|
| 2007 |
Anderson GM, Scahill L, McCracken JT, McDougle CJ, Aman MG, Tierney E, Arnold LE, Martin A, Katsovich L, Posey DJ, Shah B, Vitiello B. Effects of short- and long-term risperidone treatment on prolactin levels in children with autism. Biological Psychiatry. 61: 545-50. PMID 16730335 DOI: 10.1016/J.Biopsych.2006.02.032 |
0.367 |
|
| 2007 |
Johnson CR, Handen BL, Butter E, Wagner A, Mulick J, Sukhodolsky DG, Williams S, Swiezy NA, Arnold LE, Aman MG, Scahill L, Stigler KA, McDougle CJ, Vitiello B, Smith T. Development of a parent training program for children with pervasive developmental disorders Behavioral Interventions. 22: 201-221. DOI: 10.1002/Bin.237 |
0.428 |
|
| 2006 |
Lindsay RL, Eugene Arnold L, Aman MG, Vitiello B, Posey DJ, McDougle CJ, Scahill L, Pachler M, McCracken JT, Tierney E, Bozzolo D. Dietary status and impact of risperidone on nutritional balance in children with autism: a pilot study. Journal of Intellectual & Developmental Disability. 31: 204-9. PMID 17178532 DOI: 10.1080/13668250601006924 |
0.395 |
|
| 2006 |
Scahill L, Aman MG, McDougle CJ, McCracken JT, Tierney E, Dziura J, Arnold LE, Posey D, Young C, Shah B, Ghuman J, Ritz L, Vitiello B. A prospective open trial of guanfacine in children with pervasive developmental disorders. Journal of Child and Adolescent Psychopharmacology. 16: 589-98. PMID 17069547 DOI: 10.1089/Cap.2006.16.589 |
0.471 |
|
| 2006 |
Arnold LE, Aman MG, Cook AM, Witwer AN, Hall KL, Thompson S, Ramadan Y. Atomoxetine for hyperactivity in autism spectrum disorders: placebo-controlled crossover pilot trial. Journal of the American Academy of Child and Adolescent Psychiatry. 45: 1196-205. PMID 17003665 DOI: 10.1097/01.Chi.0000231976.28719.2A |
0.437 |
|
| 2006 |
Pandina GJ, Aman MG, Findling RL. Risperidone in the management of disruptive behavior disorders. Journal of Child and Adolescent Psychopharmacology. 16: 379-92. PMID 16958564 DOI: 10.1089/Cap.2006.16.379 |
0.436 |
|
| 2006 |
Scahill L, McDougle CJ, Williams SK, Dimitropoulos A, Aman MG, McCracken JT, Tierney E, Arnold LE, Cronin P, Grados M, Ghuman J, Koenig K, Lam KS, McGough J, Posey DJ, et al. Children's Yale-Brown Obsessive Compulsive Scale modified for pervasive developmental disorders. Journal of the American Academy of Child and Adolescent Psychiatry. 45: 1114-23. PMID 16926619 DOI: 10.1097/01.Chi.0000220854.79144.E7 |
0.445 |
|
| 2006 |
Williams SK, Scahill L, Vitiello B, Aman MG, Arnold LE, McDougle CJ, McCracken JT, Tierney E, Ritz L, Posey DJ, Swiezy NB, Hollway J, Cronin P, Ghuman J, Wheeler C, et al. Risperidone and adaptive behavior in children with autism. Journal of the American Academy of Child and Adolescent Psychiatry. 45: 431-9. PMID 16601648 DOI: 10.1097/01.Chi.0000196423.80717.32 |
0.449 |
|
| 2006 |
Lecavalier L, Aman MG, Scahill L, McDougle CJ, McCracken JT, Vitiello B, Tierney E, Arnold LE, Ghuman JK, Loftin RL, Cronin P, Koenig K, Posey DJ, Martin A, Hollway J, et al. Validity of the autism diagnostic interview-revised. American Journal of Mental Retardation : Ajmr. 111: 199-215. PMID 16597187 DOI: 10.1352/0895-8017(2006)111[199:Votadi]2.0.Co;2 |
0.32 |
|
| 2006 |
Lam KS, Aman MG, Arnold LE. Neurochemical correlates of autistic disorder: a review of the literature. Research in Developmental Disabilities. 27: 254-89. PMID 16002261 DOI: 10.1016/J.Ridd.2005.03.003 |
0.359 |
|
| 2006 |
McDOUGLE CJ, Scahill L, Aman MG, Arnold LE, McCRACKEN JT, Tierney E, Vitiello B. Dr. McDougle and Colleagues Reply American Journal of Psychiatry. 163: 551-552. DOI: 10.1176/Appi.Ajp.163.3.551-A |
0.331 |
|
| 2005 |
Lord C, Wagner A, Rogers S, Szatmari P, Aman M, Charman T, Dawson G, Durand VM, Grossman L, Guthrie D, Harris S, Kasari C, Marcus L, Murphy S, Odom S, et al. Challenges in evaluating psychosocial interventions for Autistic Spectrum Disorders. Journal of Autism and Developmental Disorders. 35: 695-708; discussion . PMID 16496206 DOI: 10.1007/S10803-005-0017-6 |
0.321 |
|
| 2005 |
Aman MG, Arnold LE, McDougle CJ, Vitiello B, Scahill L, Davies M, McCracken JT, Tierney E, Nash PL, Posey DJ, Chuang S, Martin A, Shah B, Gonzalez NM, Swiezy NB, et al. Acute and long-term safety and tolerability of risperidone in children with autism. Journal of Child and Adolescent Psychopharmacology. 15: 869-84. PMID 16379507 DOI: 10.1089/Cap.2005.15.869 |
0.394 |
|
| 2005 |
Vitiello B, Davies M, Arnold LE, McDougle CJ, Aman M, McCracken JT, Scahill L, Tierney E, Posey DJ, Swiezy NB, Koenig K. Assessment of the integrity of study blindness in a pediatric clinical trial of risperidone. Journal of Clinical Psychopharmacology. 25: 565-9. PMID 16282839 DOI: 10.1097/01.Jcp.0000185426.08268.92 |
0.309 |
|
| 2005 |
Posey DJ, Aman MG, Arnold LE, Ramadan Y, Witwer A, Lindsay R, McDougle CJ, Swiezy N, Kohn A, McCracken JT, Shah B, Cronin P, McGough J, Lee LSY, Scahill L, et al. Randomized, controlled, crossover trial of methylphenidate in pervasive developmental disorders with hyperactivity Archives of General Psychiatry. 62: 1266-1274. PMID 16275814 DOI: 10.1001/Archpsyc.62.11.1266 |
0.445 |
|
| 2005 |
LeBlanc JC, Binder CE, Armenteros JL, Aman MG, Wang JS, Hew H, Kusumakar V. Risperidone reduces aggression in boys with a disruptive behaviour disorder and below average intelligence quotient: analysis of two placebo-controlled randomized trials. International Clinical Psychopharmacology. 20: 275-83. PMID 16096518 DOI: 10.1097/01.Yic.0000166403.03732.72 |
0.42 |
|
| 2005 |
Correia Filho AG, Bodanese R, Silva TL, Alvares JP, Aman M, Rohde LA. Comparison of risperidone and methylphenidate for reducing ADHD symptoms in children and adolescents with moderate mental retardation. Journal of the American Academy of Child and Adolescent Psychiatry. 44: 748-55. PMID 16034276 DOI: 10.1097/01.chi.0000166986.30592.67 |
0.314 |
|
| 2005 |
Neef NA, Bicard DF, Endo S, Coury DL, Aman MG. Evaluation of pharmacological treatment of impulsivity in children with attention deficit hyperactivity disorder. Journal of Applied Behavior Analysis. 38: 135-46. PMID 16033162 DOI: 10.1901/Jaba.2005.116-02 |
0.384 |
|
| 2005 |
McDougle CJ, Scahill L, Aman MG, McCracken JT, Tierney E, Davies M, Arnold LE, Posey DJ, Martin A, Ghuman JK, Shah B, Chuang SZ, Swiezy NB, Gonzalez NM, Hollway J, et al. Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology. The American Journal of Psychiatry. 162: 1142-8. PMID 15930063 DOI: 10.1176/Appi.Ajp.162.6.1142 |
0.436 |
|
| 2005 |
Aman M, Buitelaar J, Smedt GD, Wapenaar R, Binder C. Pharmacotherapy of disruptive behavior and item changes on a standardized rating scale: pooled analysis of risperidone effects in children with subaverage IQ. Journal of Child and Adolescent Psychopharmacology. 15: 220-32. PMID 15910206 DOI: 10.1089/Cap.2005.15.220 |
0.506 |
|
| 2005 |
Neef NA, Marckel J, Ferreri SJ, Bicard DF, Endo S, Aman MG, Miller KM, Jung S, Nist L, Armstrong N. Behavioral assessment of impulsivity: a comparison of children with and without attention deficit hyperactivity disorder. Journal of Applied Behavior Analysis. 38: 23-37. PMID 15898472 DOI: 10.1901/Jaba.2005.146-02 |
0.464 |
|
| 2005 |
Aman MG, Lam KS, Van Bourgondien ME. Medication patterns in patients with autism: temporal, regional, and demographic influences. Journal of Child and Adolescent Psychopharmacology. 15: 116-26. PMID 15741793 DOI: 10.1089/Cap.2005.15.116 |
0.309 |
|
| 2005 |
Vitiello B, Aman MG, Scahill L, McCracken JT, McDougle CJ, Tierney E, Davies M, Arnold LE. Research knowledge among parents of children participating in a randomized clinical trial. Journal of the American Academy of Child and Adolescent Psychiatry. 44: 145-9. PMID 15689727 DOI: 10.1097/00004583-200502000-00006 |
0.339 |
|
| 2004 |
Lecavalier L, Aman MG, Hammer D, Stoica W, Mathews GL. Factor analysis of the Nisonger Child Behavior Rating Form in children with autism spectrum disorders. Journal of Autism and Developmental Disorders. 34: 709-21. PMID 15679190 DOI: 10.1007/S10803-004-5291-1 |
0.464 |
|
| 2004 |
Aman MG. Management of hyperactivity and other acting-out problems in patients with autism spectrum disorder. Seminars in Pediatric Neurology. 11: 225-8. PMID 15575418 DOI: 10.1016/J.Spen.2004.07.006 |
0.362 |
|
| 2004 |
Brown EC, Aman MG, Lecavalier L. Empirical classification of behavioral and psychiatric problems in children and adolescents with mental retardation. American Journal of Mental Retardation : Ajmr. 109: 445-55. PMID 15471511 DOI: 10.1352/0895-8017(2004)109<445:Ecobap>2.0.Co;2 |
0.345 |
|
| 2004 |
Aman MG, Gharabawi GM. Treatment of behavior disorders in mental retardation: report on transitioning to atypical antipsychotics, with an emphasis on risperidone. The Journal of Clinical Psychiatry. 65: 1197-210. PMID 15367046 DOI: 10.4088/Jcp.V65N0907 |
0.413 |
|
| 2004 |
Aman MG, Binder C, Turgay A. Risperidone effects in the presence/absence of psychostimulant medicine in children with ADHD, other disruptive behavior disorders, and subaverage IQ. Journal of Child and Adolescent Psychopharmacology. 14: 243-54. PMID 15319021 DOI: 10.1089/1044546041649020 |
0.46 |
|
| 2004 |
Lindsay RL, Leone S, Aman MG. Discontinuation of risperidone and reversibility of weight gain in children with disruptive behavior disorders. Clinical Pediatrics. 43: 437-44. PMID 15208748 DOI: 10.1177/000992280404300504 |
0.351 |
|
| 2004 |
Findling RL, Aman MG, Eerdekens M, Derivan A, Lyons B. Long-term, open-label study of risperidone in children with severe disruptive behaviors and below-average IQ. The American Journal of Psychiatry. 161: 677-84. PMID 15056514 DOI: 10.1176/Appi.Ajp.161.4.677 |
0.449 |
|
| 2004 |
Aman MG, Novotny S, Samango-Sprouse C, Lecavalier L, Leonard E, Gadow KD, King BH, Pearson DA, Gernsbacher MA, Chez M. Outcome measures for clinical drug trials in autism. Cns Spectrums. 9: 36-47. PMID 14999174 DOI: 10.1017/S1092852900008348 |
0.387 |
|
| 2004 |
Kutcher S, Aman M, Brooks SJ, Buitelaar J, van Daalen E, Fegert J, Findling RL, Fisman S, Greenhill LL, Huss M, Kusumakar V, Pine D, Taylor E, Tyano S. International consensus statement on attention-deficit/hyperactivity disorder (ADHD) and disruptive behaviour disorders (DBDs): clinical implications and treatment practice suggestions. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 14: 11-28. PMID 14659983 DOI: 10.1016/S0924-977X(03)00045-2 |
0.392 |
|
| 2003 |
Esbensen AJ, Rojahn J, Aman MG, Ruedrich S. Reliability and validity of an assessment instrument for anxiety, depression, and mood among individuals with mental retardation. Journal of Autism and Developmental Disorders. 33: 617-29. PMID 14714931 DOI: 10.1023/B:Jadd.0000005999.27178.55 |
0.623 |
|
| 2003 |
Arnold LE, Vitiello B, McDougle C, Scahill L, Shah B, Gonzalez NM, Chuang S, Davies M, Hollway J, Aman MG, Cronin P, Koenig K, Kohn AE, McMahon DJ, Tierney E. Parent-defined target symptoms respond to risperidone in RUPP autism study: customer approach to clinical trials. Journal of the American Academy of Child and Adolescent Psychiatry. 42: 1443-50. PMID 14627879 DOI: 10.1097/00004583-200312000-00011 |
0.336 |
|
| 2003 |
Lindsay RL, Aman MG. Pharmacologic therapies aid treatment for autism. Pediatric Annals. 32: 671-6. PMID 14606217 DOI: 10.3928/0090-4481-20031001-08 |
0.426 |
|
| 2003 |
Aman MG, Lam KS, Collier-Crespin A. Prevalence and patterns of use of psychoactive medicines among individuals with autism in the Autism Society of Ohio. Journal of Autism and Developmental Disorders. 33: 527-34. PMID 14594332 DOI: 10.1023/A:1025883612879 |
0.31 |
|
| 2003 |
Rojahn J, Aman MG, Matson JL, Mayville E. The Aberrant Behavior Checklist and the Behavior Problems Inventory: convergent and divergent validity. Research in Developmental Disabilities. 24: 391-404. PMID 12951135 DOI: 10.1016/S0891-4222(03)00055-6 |
0.638 |
|
| 2003 |
Aman MG, Buican B, Arnold LE. Methylphenidate treatment in children with borderline IQ and mental retardation: analysis of three aggregated studies. Journal of Child and Adolescent Psychopharmacology. 13: 29-40. PMID 12804124 DOI: 10.1089/104454603321666171 |
0.452 |
|
| 2003 |
Aman MG, Lindsay RL. Psychotropic Medicines and Aggressive Behavior Part II: Antipsychotics and Mood Stabilizers Child and Adolescent Psychopharmacology News. 8: 6-12. DOI: 10.1521/Capn.8.2.6.23068 |
0.412 |
|
| 2003 |
McDougle CJ, Aman MG, McCracken JT, Scahill L, Tierney E, Vitiello B. P.2.109 A double-blind placebo-controlled trial of risperidone in autistic disorder European Neuropsychopharmacology. 13. DOI: 10.1016/S0924-977X(03)92062-1 |
0.333 |
|
| 2003 |
Findling R, Aman M, Kusumakar V, Daneman D, Moshang T, Smedt GD, Binder C. Prolactin levels in children after long term treatment with risperidone Schizophrenia Research. 60: 354-355. DOI: 10.1016/S0920-9964(03)80161-5 |
0.338 |
|
| 2002 |
Langworthy-Lam KS, Aman MG, Van Bourgondien ME. Prevalence and patterns of use of psychoactive medicines in individuals with autism in the Autism Society of North Carolina. Journal of Child and Adolescent Psychopharmacology. 12: 311-21. PMID 12625991 DOI: 10.1089/104454602762599853 |
0.352 |
|
| 2002 |
Snyder R, Turgay A, Aman M, Binder C, Fisman S, Carroll A. Effects of risperidone on conduct and disruptive behavior disorders in children with subaverage IQs. Journal of the American Academy of Child and Adolescent Psychiatry. 41: 1026-36. PMID 12218423 DOI: 10.1097/00004583-200209000-00002 |
0.512 |
|
| 2002 |
Aman MG, De Smedt G, Derivan A, Lyons B, Findling RL. Double-blind, placebo-controlled study of risperidone for the treatment of disruptive behaviors in children with subaverage intelligence. The American Journal of Psychiatry. 159: 1337-46. PMID 12153826 DOI: 10.1176/Appi.Ajp.159.8.1337 |
0.427 |
|
| 2002 |
McCracken JT, McGough J, Shah B, Cronin P, Hong D, Aman MG, Arnold LE, Lindsay R, Nash P, Hollway J, McDougle CJ, Posey D, Swiezy N, Kohn A, Scahill L, et al. Risperidone in children with autism and serious behavioral problems. The New England Journal of Medicine. 347: 314-21. PMID 12151468 DOI: 10.1056/Nejmoa013171 |
0.433 |
|
| 2002 |
Brown EC, Aman MG, Havercamp SM. Factor analysis and norms for parent ratings on the Aberrant Behavior Checklist-Community for young people in special education. Research in Developmental Disabilities. 23: 45-60. PMID 12071395 DOI: 10.1016/S0891-4222(01)00091-9 |
0.409 |
|
| 2002 |
Aman MG, Armstrong S, Buican B, Sillick T. Four-year follow-up of children with low intelligence and ADHD: a replication. Research in Developmental Disabilities. 23: 119-134. PMID 12061750 DOI: 10.1016/S0891-4222(02)00090-2 |
0.477 |
|
| 2002 |
Aman MG, Lindsay RL. Psychotropic Medicines and Aggressive Behavior Child and Adolescent Psychopharmacology News. 7: 1-6. DOI: 10.1521/Capn.7.5.1.22725 |
0.399 |
|
| 2002 |
Findling RL, Aman MG, Smedt GD, Derivan A. Risperidone in children with conduct problems and subaverage IQ European Psychiatry. 17: 118. DOI: 10.1016/S0924-9338(02)80524-7 |
0.384 |
|
| 2001 |
Scahill L, McCracken J, McDougle CJ, Aman M, Arnold LE, Tierney E, Cronin P, Davies M, Ghuman J, Gonzalez N, Koenig K, Lindsay R, Martin A, McGough J, Posey DJ, et al. Methodological issues in designing a multisite trial of risperidone in children and adolescents with autism. Journal of Child and Adolescent Psychopharmacology. 11: 377-88. PMID 11838820 DOI: 10.1089/104454601317261555 |
0.427 |
|
| 2001 |
Turgay A, Aman MG, Binder C. Risperidone in children with various disruptive behavior disorders, subaverage IQ and comorbid ADHD European Neuropsychopharmacology. 11. DOI: 10.1016/S0924-977X(01)80299-6 |
0.48 |
|
| 2001 |
Findling RL, Aman MG, Smedt GD, Derivan A. Risperidone in children with significant conduct problems and subaverage intellectual functioning European Neuropsychopharmacology. 11. DOI: 10.1016/S0924-977X(01)80298-4 |
0.378 |
|
| 2001 |
Aman MG. Antipsychotics and disruptive disorders in children European Neuropsychopharmacology. 11. DOI: 10.1016/S0924-977X(01)80026-2 |
0.451 |
|
| 2000 |
Aman MG, Collier-Crespin A, Lindsay RL. Pharmacotherapy of disorders in mental retardation European Child and Adolescent Psychiatry. 9. PMID 11140785 DOI: 10.1007/S007870070023 |
0.423 |
|
| 2000 |
Aman MG, Langworthy KS. Pharmacotherapy for hyperactivity in children with autism and other pervasive developmental disorders Journal of Autism and Developmental Disorders. 30: 451-459. PMID 11098883 DOI: 10.1023/A:1005559725475 |
0.393 |
|
| 2000 |
Arnold LE, Aman MG, Martin A, Collier-Crespin A, Vitiello B, Tierney E, Asarnow R, Bell-Bradshaw F, Freeman BJ, Gates-Ulanet P, Klin A, McCracken JT, McDougle CJ, McGough JJ, Posey DJ, et al. Assessment in multisite randomized clinical trials of patients with autistic disorder: the Autism RUPP Network. Research Units on Pediatric Psychopharmacology. Journal of Autism and Developmental Disorders. 30: 99-111. PMID 10832774 DOI: 10.1023/A:1005451304303 |
0.415 |
|
| 2000 |
Aman M, Findling R, Derivan A. 490. Risperidone versus placebo for severe conduct disorder in children with mental retardation Biological Psychiatry. 47. DOI: 10.1016/S0006-3223(00)00760-5 |
0.448 |
|
| 1999 |
Aman MG, Arnold LE, Armstrong SC. Review of serotonergic agents and perseverative behavior in patients with developmental disabilities Mental Retardation and Developmental Disabilities Research Reviews. 5: 279-289. DOI: 10.1002/(Sici)1098-2779(1999)5:4<279::Aid-Mrdd5>3.0.Co;2-6 |
0.39 |
|
| 1999 |
Aman MG, Madrid A. Atypical antipsychotics in persons with developmental disabilities Mental Retardation and Developmental Disabilities Research Reviews. 5: 253-263. DOI: 10.1002/(Sici)1098-2779(1999)5:4<253::Aid-Mrdd2>3.0.Co;2-R |
0.381 |
|
| 1998 |
Shultz JM, Aman MG, Rojahn J. Psychometric evaluation of a measure of cognitive decline in elderly people with mental retardation. Research in Developmental Disabilities. 19: 63-71. PMID 9472135 DOI: 10.1016/S0891-4222(97)00029-2 |
0.602 |
|
| 1997 |
DeWitt MB, Aman MG, Rojahn J. Effects of Reinforcement Contingencies on Performance of Children with Mental Retardation and Attention Problems Journal of Developmental and Physical Disabilities. 9: 101-115. DOI: 10.1023/A:1024973618256 |
0.666 |
|
| 1996 |
Aman MG, Pejeau C, Osborne P, Rojahn J, Handen B. Four-year follow-up of children with low intelligence and ADHD. Research in Developmental Disabilities. 17: 417-32. PMID 8946568 DOI: 10.1016/S0891-4222(96)00023-6 |
0.698 |
|
| 1996 |
Tassé MJ, Aman MG, Hammer D, Rojahn J. The Nisonger child behavior rating form: Age and gender effects and norms Research in Developmental Disabilities. 17: 59-75. PMID 8750076 DOI: 10.1016/0891-4222(95)00037-2 |
0.667 |
|
| 1996 |
Aman MG, Tassé MJ, Rojahn J, Hammer D. The Nisonger CBRF: A child behavior rating form for children with developmental disabilities Research in Developmental Disabilities. 17: 41-57. PMID 8750075 DOI: 10.1016/0891-4222(95)00039-9 |
0.687 |
|
| 1996 |
Sarphare G, Aman MG. Parent- and self-ratings of anxiety in children with mental retardation: Agreement levels and test-retest reliability Research in Developmental Disabilities. 17: 27-39. PMID 8750074 DOI: 10.1016/0891-4222(95)00035-6 |
0.456 |
|
| 1996 |
Aman MG. Stimulant drugs in the developmental disabilities revisited Journal of Developmental and Physical Disabilities. 8: 347-365. DOI: 10.1007/Bf02578400 |
0.447 |
|
| 1995 |
Aman MG, Bourgondien MEV, Wolford PL, Sarphare G. Psychotropic and anticonvulsant drugs in subjects with autism: prevalence and patterns of use. Journal of the American Academy of Child and Adolescent Psychiatry. 34: 1672-1681. PMID 8543539 DOI: 10.1097/00004583-199512000-00018 |
0.329 |
|
| 1995 |
Aman MG, Wolford PL. Consumer satisfaction with involvement in drug research: A social validity study Journal of the American Academy of Child and Adolescent Psychiatry. 34: 940-945. PMID 7649965 DOI: 10.1097/00004583-199507000-00018 |
0.391 |
|
| 1995 |
Einfeld SL, Aman M. Issues in the taxonomy of psychopathology in mental retardation Journal of Autism and Developmental Disorders. 25: 143-167. PMID 7559282 DOI: 10.1007/Bf02178501 |
0.386 |
|
| 1994 |
Pearson DA, Aman MG. Ratings of hyperactivity and developmental indices: Should clinicians correct for developmental level? Journal of Autism and Developmental Disorders. 24: 395-411. PMID 7525533 DOI: 10.1007/Bf02172125 |
0.437 |
|
| 1994 |
Aman MG, Rojahn J, King EH, Logsdon DA, Marshburn EC. Prevalence and pattern of prescribed medication in 2-year-old children Journal of Developmental and Physical Disabilities. 6: 87-99. DOI: 10.1007/Bf02579352 |
0.62 |
|
| 1994 |
Aman MG, Rojahn J. The psychometric characteristics of the preschool behavior questionnaire in preschoolers with developmental handicaps Journal of Developmental and Physical Disabilities. 6: 311-325. DOI: 10.1007/Bf02578418 |
0.649 |
|
| 1993 |
Aman MG, Kern RA, McGHEE DE, Arnold LE. Fenfluramine and Methylphenidate in Children with Mental Retardation and ADHD: Clinical and Side Effects Journal of the American Academy of Child and Adolescent Psychiatry. 32: 851-859. PMID 8340309 DOI: 10.1097/00004583-199307000-00022 |
0.479 |
|
| 1993 |
Aman MG, Kern RA, McGhee DE, Arnold LE. Fenfluramine and methylphenidate in children with mental retardation and attention deficit hyperactivity disorder: Laboratory effects Journal of Autism and Developmental Disorders. 23: 491-506. PMID 8226583 DOI: 10.1007/Bf01046052 |
0.446 |
|
| 1993 |
Aman MG. Efficacy of psychotropic drugs for reducing self-injurious behavior in the developmental disabilities Annals of Clinical Psychiatry. 5: 171-188. PMID 7904217 DOI: 10.3109/10401239309148981 |
0.337 |
|
| 1992 |
Aman MG, Werry JS, Turbott SH. Behavior of children with seizures. Comparison with norms and effect of seizure type. Journal of Nervous and Mental Disease. 180: 124-129. PMID 1737974 DOI: 10.1097/00005053-199202000-00010 |
0.344 |
|
| 1992 |
Marshburn EC, Aman MG. Factor validity and norms for the Aberrant Behavior Checklist in a community sample of children with mental retardation Journal of Autism and Developmental Disorders. 22: 357-373. PMID 1383187 DOI: 10.1007/Bf01048240 |
0.373 |
|
| 1991 |
Arnold LE, Aman MG. Beta blockers in mental retardation and developmental disorders. Journal of Child and Adolescent Psychopharmacology. 1: 361-373. PMID 19630686 DOI: 10.1089/Cap.1991.1.361 |
0.403 |
|
| 1991 |
Aman MG, Marks RE, Turbott SH, Wilsher CP, Merry SN. Clinical Effects of Methylphenidate and Thioridazine in Intellectually Subaverage Children Journal of the American Academy of Child and Adolescent Psychiatry. 30: 246-256. PMID 2016229 DOI: 10.1097/00004583-199103000-00013 |
0.474 |
|
| 1991 |
Aman MG, Turbott SH. Prediction of clinical response in children taking methylphenidate Journal of Autism and Developmental Disorders. 21: 211-228. PMID 1864828 DOI: 10.1007/Bf02284761 |
0.383 |
|
| 1991 |
Aman MG, Marks RE, Turbott SH, Wilsher CP, Merry SN. Methylphenidate and thioridazine in the treatment of intellectually subaverage children: effects on cognitive-motor performance. Journal of the American Academy of Child and Adolescent Psychiatry. 30: 816-824. DOI: 10.1016/S0890-8567(10)80022-X |
0.347 |
|
| 1989 |
Aman MG, Kern RA. Review of fenfluramine in the treatment of the developmental disabilities Journal of the American Academy of Child and Adolescent Psychiatry. 28: 549. PMID 2670881 DOI: 10.1097/00004583-198907000-00014 |
0.411 |
|
| 1988 |
Watson JE, Aman MG, Singh NN. The psychopathology instrument for mentally retarded adults: psychometric characteristics, factor structure, and relationship to subject characteristics. Research in Developmental Disabilities. 9: 277-290. PMID 3175094 DOI: 10.1016/0891-4222(88)90005-4 |
0.302 |
|
| 1988 |
Aman MG, White AJ. Thioridazine dose effects with reference to stereotypic behavior in mentally retarded residents Journal of Autism and Developmental Disorders. 18: 355-366. PMID 3170454 DOI: 10.1007/Bf02212192 |
0.357 |
|
| 1987 |
Aman MG, Singh NN, White AJ. Caregiver perceptions of psychotropic medication in residential facilities Research in Developmental Disabilities. 8: 449-465. PMID 3671821 DOI: 10.1016/0891-4222(87)90025-4 |
0.334 |
|
| 1987 |
Aman MG, Mitchell EA, Turbott SH. The effects of essential fatty acid supplementation by efamol in hyperactive children Journal of Abnormal Child Psychology. 15: 75-90. PMID 3553274 DOI: 10.1007/Bf00916467 |
0.407 |
|
| 1987 |
Mitchell EA, Aman MG, Turbott SH, Manku M. Clinical Characteristics and Serum Essential Fatty Acid Levels in Hyperactive Children Clinical Pediatrics. 26: 406-411. PMID 2439249 DOI: 10.1177/000992288702600805 |
0.374 |
|
| 1986 |
Aman MG, Turbott SH. Incidental learning, distraction, and sustained attention in hyperactive and control subjects Journal of Abnormal Child Psychology. 14: 441-455. PMID 3760349 DOI: 10.1007/Bf00915437 |
0.32 |
|
| 1986 |
Aman MG, White AJ, Vaithianathan C, Teehan CJ. Preliminary study of imipramine in profoundly retarded residents. Journal of Autism and Developmental Disorders. 16: 263-273. PMID 3549681 DOI: 10.1007/Bf01531659 |
0.377 |
|
| 1986 |
Aman MG, Singh NN. A critical appraisal of recent drug research in mental retardation: The Coldwater studies Journal of Mental Deficiency Research. 30: 203-216. PMID 2878082 DOI: 10.1111/J.1365-2788.1986.Tb01315.X |
0.325 |
|
| 1985 |
Aman MG, Singh NN. Dyskinetic symptoms in profoundly retarded residents following neuroleptic withdrawal and during methylphenidate treatment Journal of Mental Deficiency Research. 29: 187-195. PMID 2863380 DOI: 10.1111/J.1365-2788.1985.Tb00327.X |
0.306 |
|
| 1985 |
White TJR, Aman MG. Pimozide treatment in disruptive severely retarded patients Australasian Psychiatry. 19: 92-94. DOI: 10.3109/00048678509158820 |
0.304 |
|
| 1984 |
Aman MG, White AJ, Field C. Chlorpromazine effects on stereotypic and conditioned behaviour of severely retarded patients - a pilot study Journal of Mental Deficiency Research. 28: 253-260. PMID 6396416 DOI: 10.1111/J.1365-2788.1984.Tb01018.X |
0.305 |
|
| 1984 |
Aman MG, Vamos M, Werry JS. Effects of methylphenidate in normal adults with reference to drug action in hyperactivity Australian and New Zealand Journal of Psychiatry. 18: 86-88. PMID 6380485 DOI: 10.3109/00048678409161040 |
0.415 |
|
| 1984 |
Aman MG. Hyperactivity: Nature of the syndrome and its natural history Journal of Autism and Developmental Disorders. 14: 39-56. PMID 6368521 DOI: 10.1007/Bf02408554 |
0.464 |
|
| 1984 |
Aman MG, Werry JS. The revised behavior problem checklist in clinic attenders and non‐attenders: Age and sex effects Journal of Clinical Child Psychology. 13: 237-242. DOI: 10.1080/15374418409533196 |
0.446 |
|
| 1983 |
Aman MG, Werry JS, Fitzpatrick J, Lowe M, Waters J. Factor Structure and Norms for the Revised Behavior Problem Checklist in New Zealand Children Australian and New Zealand Journal of Psychiatry. 17: 354-360. PMID 6581794 DOI: 10.1080/00048678309160013 |
0.443 |
|
| 1982 |
Aman MG, Singh NN. Methylphenidate in severely retarded residents and the clinical significance of stereotypic behavior Applied Research in Mental Retardation. 3: 345-358. PMID 7168571 DOI: 10.1016/S0270-3092(82)80002-7 |
0.338 |
|
| 1982 |
Aman MG, Werry JS. Methylphenidate and Diazepam in Severe Reading Retardation Journal of the American Academy of Child Psychiatry. 21: 31-37. PMID 7047619 DOI: 10.1097/00004583-198201000-00007 |
0.372 |
|
| 1982 |
Aman MG. Stimulant drug effects in developmental disorders and hyperactivity - Toward a resolution of disparate findings Journal of Autism and Developmental Disorders. 12: 385-398. PMID 6131061 DOI: 10.1007/Bf01538326 |
0.425 |
|
| 1980 |
Aman MG. Psychotropic drugs and learning problems - a selective review Journal of Learning Disabilities. 13: 87-97. PMID 7391681 DOI: 10.1177/002221948001300208 |
0.327 |
|
| 1980 |
Werry JS, Aman MG, Diamond E. Imipramine and methylphenidate in hyperactive children Journal of Child Psychology and Psychiatry and Allied Disciplines. 21: 27-35. PMID 7358801 DOI: 10.1111/J.1469-7610.1980.Tb00013.X |
0.378 |
|
| 1979 |
Aman MG. Cognitive, social, and other correlates of specific reading retardation Journal of Abnormal Child Psychology. 7: 153-168. PMID 469109 DOI: 10.1007/Bf00918896 |
0.385 |
|
| 1976 |
Werry JS, Aman MG. The reliability and diagnostic validity of the physical and neurological examination for soft signs (PANESS) Journal of Autism and Childhood Schizophrenia. 6: 253-262. PMID 1036492 DOI: 10.1007/Bf01543465 |
0.435 |
|
| 1975 |
Aman MG, Werry JS. The effects of methylphenidate and haloperidol on the heart rate and blood pressure of hyperactive children with special reference to time of action Psychopharmacologia. 43: 163-168. PMID 1103207 DOI: 10.1007/Bf00421019 |
0.311 |
|
| 1975 |
Werry JS, Aman MG. Methylphenidate and Haloperidol in Children: Effects on Attention, Memory, and Activity Archives of General Psychiatry. 32: 790-795. PMID 1093506 DOI: 10.1001/Archpsyc.1975.01760240118009 |
0.387 |
|
| Show low-probability matches. |